Merck & Company, Inc. ( MRK ) will begin trading ex-dividend on March 14, 2019. A cash dividend payment of $0.55 per share is scheduled to be paid on April 05, 2019. Shareholders who purchased MRK prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 14.58% increase over prior dividend payment.
The previous trading day's last sale of MRK was $81.23, representing a -1.08% decrease from the 52 week high of $82.12 and a 53.76% increase over the 52 week low of $52.83.
MRK is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and Pfizer, Inc. ( PFE ). MRK's current earnings per share, an indicator of a company's profitability, is $2.32. Zacks Investment Research reports MRK's forecasted earnings growth in 2019 as 7.1%, compared to an industry average of 2.4%.
Interested in gaining exposure to MRK through an Exchange Traded Fund [ETF]?
The following ETF(s) have MRK as a top-10 holding:
- iShares U.S. Pharmaceutical ETF ( IHE )
- SPDR Select Sector Fund - Health Care ( XLV )
- iShares U.S. Healthcare ETF ( IYH )
- VanEck Vectors Pharmaceutical ETF ( PPH )
- RiverFront Dynamic US Dividend Advantage ETF ( RFDA ).
The top-performing ETF of this group is RFDA with an increase of 0.8% over the last 100 days. IHE has the highest percent weighting of MRK at 9.67%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.